Nancy Valente

Affiliations

  • Evp, Chief Development Officer at Xencor Inc (XNCR), 2025-03-11
  • Director at Myovant Sciences Ltd. (MYOV), 2023-03-10
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XNCR $13.60 2,565 Officer 53,785 2025-03-10 Filing
XNCR $23.58 4,745 Officer 55,115 2024-05-02 Filing